A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.
The U.S. Food and Drug Administration approved Eli Lilly’s drug, named Zepbound. The drug, also known as tirzepatide, helped dieters lose as much as 40 to 60 pounds in testing.
Manjaro? I use that on my computer!
Oh, you said Mounjaro? Never mind.
I’m on Wegovy and it’s a miracle, frankly.
Between the ADHD medication wreaking havoc with my hunger signals and the non-diabetic hypoglycemia causing me to go from “not hungry” to “dying of a sugar crash,” the Wegovy gave me actual satiety for the first time in my life, and evened out the crashes.
I’m a big fan of more options along these lines, for whoever they might save.
The track record for weight loss drugs is not good. Even “approved” ones. We had a lot of teenagers on amphetamines to make them lose weight.
The podcast Maintenance Phase has at least one episode on them and their history.
I’m personally a big fan of consuming fewer calories.
